Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2026-06-08 16:27:32 ET · period of report 2026-06-05 · accession 0001650131-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-08 16:27 | 2026-06-05 | MIRM | Radovich Peter | Pres AND COO | M - OptEx | $19.19 | +17.0K | 57.3K | +42% | +$326.0K |
| D | 2026-06-08 16:27 | 2026-06-05 | MIRM | Radovich Peter | Pres AND COO | M - OptEx | $0.00 | -17.0K | 48.0K | -26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-05 | M | A | 16,988 | $19.19 | 57,260 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2026-06-05 | M | D | 16,988 | $0.00 | 48,012 | D | $19.19 · — to 2031-01-06 | 16,988 Common Stock | (F1) The stock option is fully vested. |